A Study of ASP2138 in Adults With Stomach Cancer or Pancreatic Cancer.
Phase 1
- Conditions
- Gastroesophageal Junction (GEJ) Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic AdenocarcinomaTherapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2023-504514-29-00
- Lead Sponsor
- Astellas Pharma Global Development Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 240
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method